Impact of inherited and acquired prothrombotic defects (PD) on the development of symptomatic thromboembolism (STE) in children with acute lymphoblastic leukemia (ALL) treated according to the Dana-Farber Cancer Institute (DFCI) 05-01 All-Therapy Protocol Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • June 1, 2015